NCT02003547View on ClinicalTrials.gov

A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

GlaucomaOcular HypertensionEye Disease

Interventions

DRUG

AMA0076

DRUG

Placebo

Trial Locations (1)

NG11 6GS

Ruddington

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amakem, NV

INDUSTRY

NCT02003547 - A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects | Biotech Hunter | Biotech Hunter